gatifloxacin has been researched along with ro13-9904 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Dresser, LD; Niederman, MS; Paladino, JA | 1 |
| Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL | 1 |
| Appelbaum, PC; Bozdogan, B; Browne, FA; Clark, C; Dewasse, BE; Jacobs, MR | 1 |
| Badaró, R; Bumroongkit, C; Corrêa, JC; Dolmann, AL; Juárez Martínez, LG; Mayrinck, LR; Mera, JR; Tamez, R; Yang, JY | 1 |
| Bentzel, DE; Brook, I; Elliott, TB; Keller, CE; Knudson, GB; Shoemaker, MO | 1 |
| Badaró, R; Corrêa, JC; Mendonça, JS; Yamaguti, A | 1 |
| Burgess, DS; Frei, CR | 1 |
| Kenton, I; McKinnon, PS; Mohr, JF; Okhuysen, PC; Peymann, PJ; Septimus, E | 1 |
| Dean, NC; Hadlock, C; Sperry, P; Suchyta, MS; Wikler, M | 1 |
| Hatton, RC; Onyenwenyi, AJ; Winterstein, AG | 1 |
| Butler, T | 1 |
| Adhikari, N; Arjyal, A; Baker, S; Basnyat, B; Dolecek, C; Dongol, S; Gajurel, D; Giri, A; Joshi, N; Karkey, A; Koirala, S; Lamsal, D; Lamsal, K; Mahat, SP; Merson, L; Nhan, HT; Pathak, KR; Prajapati, SP; Shah, G; Shakya, M; Shrestha, P; Thanh, DP; Thapa, R; Thieu, NTV; Thompson, CN; Thwaites, GE; Wolbers, M; Yadav, BK | 1 |
| Arjyal, A; Baker, S; Basnyat, B; Dolecek, C; Dongol, S; Dougan, G; Gajurel, D; Ha Thanh, T; Ho Thi, N; Holt, KE; Karkey, A; Parry, CM; Pham Thanh, D; Pickard, D; Pradhan, A; Rabaa, MA; Shrestha, SK; Thompson, CN; Thwaites, GE; Tran Vu Thieu, N; Voong Vinh, P; Wolbers, M; Wong, V | 1 |
| Arjyal, A; Baker, S; Basnyat, B; Darton, T; Dolecek, C; Dongol, S; Farrar, JJ; Karkey, A; Thompson, CN; Thwaites, GE; Wolbers, M | 1 |
1 review(s) available for gatifloxacin and ro13-9904
| Article | Year |
|---|---|
Treatment of typhoid fever in the 21st century: promises and shortcomings.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clinical Trials as Topic; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2011 |
7 trial(s) available for gatifloxacin and ro13-9904
| Article | Year |
|---|---|
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Female; Fluoroquinolones; Gatifloxacin; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 2001 |
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia | 2003 |
Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Community-Acquired Infections; Female; Fluoroquinolones; Gatifloxacin; Humans; Macrolides; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 2004 |
Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Length of Stay; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 2006 |
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Nepal; Salmonella enterica; Salmonella typhi; Treatment Failure; Typhoid Fever; Young Adult | 2016 |
A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Genotype; Humans; Nepal; Salmonella typhi; Sequence Analysis, DNA; Treatment Failure; Typhoid Fever | 2016 |
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Nepal; Ofloxacin; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Treatment Failure; Treatment Outcome; Typhoid Fever; Young Adult | 2017 |
7 other study(ies) available for gatifloxacin and ro13-9904
| Article | Year |
|---|---|
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2002 |
Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Selection, Genetic; Streptococcus pneumoniae | 2002 |
Antimicrobial therapies for pulmonary Klebsiella pneumoniae infection in B6D2F1/J mice immunocompromised by use of sublethal irradiation.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Combinations; Female; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred Strains; Pneumonia, Bacterial; Survival Rate; Whole-Body Irradiation | 2004 |
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
Topics: Anti-Bacterial Agents; Area Under Curve; Ceftriaxone; Computer Simulation; Databases, Factual; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intravenous; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Ofloxacin; Streptococcus pneumoniae | 2005 |
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies | 2005 |
An evaluation of the effects of gatifloxacin on glucose homeostasis.
Topics: Adult; Aged; Anti-Bacterial Agents; Blood Glucose; Bronchitis; Ceftriaxone; Cohort Studies; Community-Acquired Infections; Diabetes Mellitus; Female; Fluoroquinolones; Gatifloxacin; Homeostasis; Hospitalization; Humans; Hyperglycemia; Hypoglycemia; Male; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; United States | 2008 |